Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-09-25Absorption of Anti-tuberculosis Drugs and Its Effect to Treatment Response in Gastrectomized Patients
-
CLINICAL_TRIALS study record update · 2020-09-16A Randomized, Controlled, Multi-center Clinical Trial of Short Course Treatment for Newly Diagnosed Rifampicin Resistant Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-09-09A Trial of Vitamin D Supplementation Among Tuberculosis Patients in South India
-
CLINICAL_TRIALS study record update · 2020-08-31Conception and Validation of a Clinico-radiological Classification of Peritoneal Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-08-31A Phase I Trial to Compare the Safety and Immunogenicity of Candidate TB Vaccine MVA85A Administered by the Aerosol Inhaled Route and the Intramuscular Route in Healthy Adult Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-08-28ClinicalTrials.gov study NCT02501421
-
CLINICAL_TRIALS study record update · 2020-08-18Randomized Controlled Trial of a Protein-calorie Supplement for HIV-infected Women With Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-08-14Efficacy and Safety of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients Receiving Rifampicin Based Anti-TB Therapy
-
CLINICAL_TRIALS study record update · 2020-08-05A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-07-29Identifcation of Biomarkers for Active Pulmonary Tuberculosis Using a Metabolomics Approach: a Prospective Multicenter Study
-
CLINICAL_TRIALS study record update · 2020-07-17A 48 Week, Randomized, Open-label, 2 Arm Study to Compare the Efficacy, Safety and Tolerability of HAART Containing Nevirapine 400mg/Day Versus Nevirapine 600 mg/Day in HIV-1 Infected Patients Started at 2-6 Weeks After Initiating Rifampin Containing Antituberculous Therapy
-
CLINICAL_TRIALS study record update · 2020-07-17The Pharmacokinetics and Safety of Ritonavir-boosted Indinavir 600/100mg Bid Combined With NRTIs in ARV naïve HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2020-07-17A Pilot Study of the Pharmacokinetics and Safety of Lopinavir/Ritonavir 400/100mg Bid Versus Lopinavir/Ritonavir 600/150 mg BID Combined With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2020-06-30Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months for Tuberculosis Preventive Treatment: A Randomized Controlled Study in China
-
CLINICAL_TRIALS study record update · 2020-06-29A Prospective Cohort Study on the Effect of Latent Infection of Tuberculosis on the Pregnancy Outcome of IVF-ET in Infertile Patients With Radiographic Lesions Suggesting Old Healed Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-05-06A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2020-04-29The Role of Interferon Gamma Releasing Assays (IGRA) in Screening and Monitoring for Tuberculosis During Anti-TNF Therapy in Patients With Immune-mediated Inflammatory Disease (IMID)
-
CLINICAL_TRIALS study record update · 2020-04-13Open-label Prospective Noncomparative Study of Safety, Tolerability and Pharmacokinetics of PBTZ169 After Single and Multiple Fasting Oral Administration in Increasing Doses in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-03-31Randomized Evaluation of a Conditional Cash Transfer Program for Routine Immunizations of Infants in Nigeria
-
CLINICAL_TRIALS study record update · 2020-03-27The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia: a Therapeutic Drug Monitoring (TDM) Approach
-
CLINICAL_TRIALS study record update · 2020-03-24Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi
-
CLINICAL_TRIALS study record update · 2020-03-24Acceptability and Completion Rates of a New 12 Dose Treatment (3 Month) Compared to the Standard Treatment for Latent TB Infection Treatment
-
CLINICAL_TRIALS study record update · 2020-03-19AIDS Defining Opportunistic Infections in Naive HIV Cases
-
CLINICAL_TRIALS study record update · 2020-03-18Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation: a National Multicenter Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-03-09Multicenter, Open, Randomized Study With Active Control to Evaluate the Early Bactericidal Activity, Safety and Pharmacokinetics of the Drug PBTZ169 When Used in Patients With First-diagnosed Tuberculosis of the Respiratory System With Bacterial Excretion and Saved Bacterial Susceptibility to Isoniazid and Rifampicin